Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07822789) titled 'Chidamide in HR-AML' on Sept. 4.

Study Type: Observational

Primary Sponsor: Guangdong Second Provincial General Hospital

Condition: Acute Myeloid Leukemia Maintenance Therapy

Recruitment Status: Not recruiting

Date of First Enrollment: July 27, 2026

Target Sample Size: 33

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07822789

Published by HT Digital Content Services with permission from Health Daily Digest....